A client has experienced persistent low mood, insomnia, decreased appetite, impaired concentration, and anhedonia for three years; does this meet criteria for major depressive disorder?

Major Depressive Disorder Diagnosis

Yes, this client meets diagnostic criteria for major depressive disorder (MDD), not persistent depressive disorder (dysthymia), because they exhibit at least five of the nine required symptoms during a sustained period, including both core symptoms of depressed mood and anhedonia. 1

Diagnostic Confirmation

Core Symptom Requirements Met

• MDD requires ≥5 of 9 DSM-5 symptoms present during the same 2-week period, with at least one being either depressed mood or anhedonia 2, 1, 3.
• This client demonstrates both mandatory core symptoms: persistent low mood (depressed mood) and loss of enjoyment in social activities (anhedonia) 1, 4.
• Anhedonia is particularly significant as it discriminates severe depression from moderate depression and should never be overlooked in diagnosis 4, 5.

Complete Symptom Count

The client presents with at least 5 qualifying symptoms 1:

1. Low mood (depressed mood nearly every day) 1
2. Anhedonia (does not enjoy social activity) 1
3. Sleep disturbance (difficulty sleeping/insomnia) 1
4. Appetite change (low appetite) 1
5. Impaired concentration (low concentration) 1

Duration Criterion Analysis

• The 3-year duration is critical for differential diagnosis 6.
• MDD requires symptoms for ≥2 weeks, while persistent depressive disorder (dysthymia) requires ≥2 years of continuous symptoms 2, 6.
• However, the presence of ≥5 symptoms with marked severity overrides the duration-based dysthymia diagnosis and indicates MDD, even when symptoms persist beyond 2 years 6.
• The symptom profile here—with prominent neurovegetative symptoms (sleep, appetite) and cognitive impairment (concentration)—is characteristic of MDD rather than dysthymia 1, 6.

Severity Assessment

Likely Moderate-to-Severe Depression

• Severity grading depends on symptom count, intensity, and functional impairment 1.
• Mild MDD: 5–6 symptoms with minimal functional impairment 1.
• Moderate MDD: Symptom burden between mild and severe 1.
• Severe MDD: All 9 symptoms present, OR severe functional impairment (inability to work/leave home), OR suicidal plan/intent, OR psychotic features, OR marked psychomotor retardation 1.
• This client's 3-year chronicity and withdrawal from social activities suggest at least moderate functional impairment, warranting classification as moderate or possibly severe MDD 1.

Critical Diagnostic Pitfalls

Do Not Misdiagnose as Dysthymia

• Clinicians commonly err by assuming chronic symptoms (>2 years) automatically indicate dysthymia 6.
• The key differentiator is symptom count and severity, not duration alone 6.
• When ≥5 symptoms are present with marked impairment, MDD is diagnosed regardless of chronicity 6.
• Dysthymia is reserved for <5 symptoms persisting ≥2 years with less severe day-to-day impairment 6.

Assess for Suicidal Ideation Immediately

• Recurrent thoughts of death or suicidal ideation are among the 9 diagnostic criteria 1.
• The presence of a specific suicide plan, clear intent, or recent attempt automatically classifies the episode as severe and requires emergency intervention 1.
• Always explicitly ask about suicidal thoughts, as patients may not volunteer this information 7.

Rule Out Medical Causes First

• Do not diagnose MDD if symptoms are attributable to a general medical condition (e.g., hypothyroidism, anemia) or substance effects (medications, drugs of abuse) 2, 1.
• Recommended screening labs: TSH, CBC, comprehensive metabolic panel, vitamin B12, vitamin D 3.
• Treat underlying medical causes (e.g., pain, fatigue, delirium) before attributing symptoms solely to MDD 8.

Recommended Next Steps

Formal Screening and Diagnostic Confirmation

• Administer the PHQ-9 (Patient Health Questionnaire-9) as a validated screening tool 8, 7, 3.
• PHQ-9 score ≥10 indicates moderate depression and warrants full diagnostic evaluation 8.
• A positive response to PHQ-9 item 9 (thoughts of death/self-harm) requires immediate safety assessment 1.
• Follow positive screens with a structured diagnostic interview using DSM-5 criteria to confirm MDD and assess severity 7.

Functional Impairment Documentation

• Symptoms must cause clinically significant distress or impairment in social, occupational, or other important functioning 9, 1.
• Document specific impairments: inability to work, withdrawal from relationships, neglect of self-care, or inability to perform daily activities 1.

Treatment Initiation

• For moderate-to-severe MDD, initiate either pharmacotherapy (second-generation antidepressants) or evidence-based psychotherapy (cognitive-behavioral therapy, interpersonal therapy) 10, 3.
• All second-generation antidepressants (SSRIs, SNRIs, bupropion, mirtazapine) are equally effective for treatment-naïve patients; choose based on side-effect profile, cost, and dosing convenience 10.
• Assess clinical response within 1–2 weeks; if inadequate response by 6–8 weeks, modify treatment 1.
• Continue treatment for at least 4–9 months after remission for a first episode; longer for recurrent episodes 10, 1.

Monitoring and Safety

• Schedule follow-up within 1–2 weeks of initiating any intervention to evaluate efficacy and adverse effects 1.
• Approximately 63% of patients on second-generation antidepressants experience at least one adverse effect; nausea, sexual dysfunction, and insomnia are most common 10.
• Monitor for treatment-emergent suicidal ideation, especially in adults under age 30 10.